Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 16, 2025, Ironwood Pharmaceuticals (IRWD) has a market cap of $0.12 billion USD. According to our data, Ironwood Pharmaceuticals is ranked No.7453 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 16, 2025 | $0.12 B |
-83.52%
|
| Dec 31, 2024 | $0.71 B |
-61.28%
|
| Dec 29, 2023 | $1.83 B |
-7.67%
|
| Dec 30, 2022 | $1.98 B |
6.26%
|
| Dec 31, 2021 | $1.87 B |
2.37%
|
| Dec 31, 2020 | $1.82 B |
-14.43%
|
| Dec 31, 2019 | $2.13 B |
53.40%
|
| Dec 31, 2018 | $1.39 B |
-30.89%
|
| Dec 29, 2017 | $2.01 B |
-1.96%
|
| Dec 30, 2016 | $2.05 B |
31.92%
|
| Dec 31, 2015 | $1.55 B |
-24.35%
|
| Dec 31, 2014 | $2.05 B |
31.96%
|
| Dec 31, 2013 | $1.56 B |
4.78%
|
| Dec 31, 2012 | $1.49 B |
-7.44%
|
| Dec 30, 2011 | $1.60 B |
15.65%
|
| Dec 31, 2010 | $1.39 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Vertex Pharmaceuticals
VRTX
|
$128.67 B |
-0.003 M
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
USA
|
 Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
USA
|
 Amgen
AMGN
|
$158.77 B |
0.132 B
|
USA
|
 Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
USA
|
 Biogen
BIIB
|
$17.12 B |
0.000 M
|
USA
|
 Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
USA
|
 Sanofi
SNY
|
$123.58 B |
-0.002 M
|
France
|
 AstraZeneca
AZN
|
$210.42 B |
-0.005 M
|
UK
|
 Merck
MRK
|
$197.26 B |
0.003 M
|
USA
|
 Novartis
NVS
|
$217.12 B |
0.003 M
|
Switzerland
|
 Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
USA
|
 Pfizer
PFE
|
$127.27 B |
-0.003 M
|
USA
|
 AbbVie
ABBV
|
$312.76 B |
-0.013 M
|
USA
|
| Market Cap | = | IRWD Stock Price | * | IRWD Shares Outstanding |
| = | $0.72 | * | 0.16 B | |
| = | $0.12 B |